期刊
MOLECULAR PHARMACOLOGY
卷 58, 期 4, 页码 852-858出版社
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.58.4.852
关键词
-
资金
- NIEHS NIH HHS [ES04917, ES000834, ES09106] Funding Source: Medline
We previously demonstrated differential interactions of the methoxychlor metabolite 2,2- bis(p-hydroxyphenyl)-1,1,1-trichloroethane(HPTE) with estrogen receptor alpha (ER alpha), ER beta, and the androgen receptor (AR). In this study, we characterize the ER alpha, ER beta, and AR activity of structurally related methoxychlor metabolites. Human hepatoma cells (HepG2) were transiently transfected with human ER alpha, ER beta, and AR plus an appropriate steroid-responsive luciferase reporter vector. After transfection, cells were treated with various concentrations of HPTE or structurally related compounds in the presence (for detecting antagonism) and absence (for detecting agonism) of 17 beta-estradiol and dihydrotestosterone. The monohydroxy analog of methoxychlor, as well as monohydroxy and dihydroxy analogs of 2,2- bis(p-hydroxyphenyl)-1,1-dichloroethylene, had ER alpha agonist activity and ER beta and AR antagonist activity similar to HPTE. The trihydroxy metabolite of methoxychlor displayed only weak ER alpha agonist activity and did not alter ER beta or AR activities. Replacement of the trichloroethane or dichloroethylene group with a methyl group resulted in a compound with ER alpha and ER beta agonist activity that retained antiandrogenic activities. This study identifies some of the structural requirements for ER alpha and ER beta activity and demonstrates the complexity involved in determining the mechanism of action of endocrine-active chemicals that simultaneously act as agonists or antagonists through one or more hormone receptors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据